Literature DB >> 7947010

Frequency and importance of change in blast cell karyotype in relapsing childhood lymphoblastic leukemia.

A J Vora1, A M Potter, L M Anderson, J S Lilleyman.   

Abstract

Blast cell chromosome abnormalities at presentation in childhood acute lymphoblastic leukemia (ALL) are common, and different patterns are known to be related to outcome. In contrast, the frequency and importance of further changes at the time of relapse remain unclear. Blast cell karyotype evolution was therefore studied in a group of children with recurrent disease. Of 134 consecutive children diagnosed between 1982 and 1992, 31 had a marrow relapse, and 24 had complete cytogenetic studies at both diagnosis and the time of recurrence. Fourteen (58%) of the 24 showed additional chromosomal abnormalities at relapse, 5 (21%) retained abnormalities identical to those seen at diagnosis, and 5 (21%) remained cytogenetically normal. The 14 with additional changes had shorter first remissions and showed shorter survival after relapse compared with the others. These findings indicate that emergency of cytogenetically recognizable subclones during the progression of childhood ALL could be a marker of more resistant disease.

Entities:  

Mesh:

Year:  1994        PMID: 7947010     DOI: 10.3109/08880019409140537

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  4 in total

1.  Changes in cytomorphology of childhood lymphoblastic leukaemia at the time of disease relapse. Childhood Leukaemia Working Party of the United Kingdom Medical Research Council.

Authors:  J S Lilleyman; R F Stevens; I M Hann; B E Gibson; J A Britton; P J Darbyshire; A Oakhill
Journal:  J Clin Pathol       Date:  1995-11       Impact factor: 3.411

2.  Evaluation of prognostic factors in patients with relapsed AML: Clonal evolution versus residual disease.

Authors:  Hyojeong Kim; Young Mi Seol; Moo-Kon Song; Young Jin Choi; Ho-Jin Shin; Sang Hyuk Park; Eun Yup Lee; Joo-Seop Chung
Journal:  Blood Res       Date:  2016-09-23

3.  Karyotypic change between diagnosis and relapse as a predictor of salvage therapy outcome in AML patients.

Authors:  Yundeok Kim; Jieun Jang; Shin Yong Hyun; Dohyu Hwang; Soo Jeong Kim; Jin Seok Kim; Jun-Won Cheong; Yoo Hong Min
Journal:  Blood Res       Date:  2013-03-25

4.  Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia.

Authors:  Julie A E Irving; Amir Enshaei; Catriona A Parker; Rosemary Sutton; Roland P Kuiper; Amy Erhorn; Lynne Minto; Nicola C Venn; Tamara Law; Jiangyan Yu; Claire Schwab; Rosanna Davies; Elizabeth Matheson; Alysia Davies; Edwin Sonneveld; Monique L den Boer; Sharon B Love; Christine J Harrison; Peter M Hoogerbrugge; Tamas Revesz; Vaskar Saha; Anthony V Moorman
Journal:  Blood       Date:  2016-05-26       Impact factor: 22.113

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.